CDKN2A and acute lymphoblastic leukemia: It should be noted that deletions of the CDKN2A/B and RB1 suppressor genes are present in T-ALL (70% and 12%, respectively) and B-ALL (36% and 8%, respectively) in which they contribute to the disruption of the tumor suppressor pathways in ALL [11,67].